The metabolic syndrome: A high-risk state for cancer?
The metabolic syndrome is composed of cardiovascular risk factors including increased body mass index/waist circumference, blood pressure, plasma glucose, and triglycerides, as well as decreased high-density lipoprotein cholesterol. The essence of the metabolic syndrome lies in the clustering of these risk factors, which are associated with cardiovascular disease. Interestingly, most of the components of the metabolic syndrome have individually been linked in some way to the development of cancer. However, epidemiological studies linking the metabolic syndrome to cancer are scarce. Nevertheless, two such studies indicate that the clustering of metabolic syndrome components significantly increases the risk of colon cancer mortality compared with the individual components. The purpose of this review is to further explore the potential relationship between the metabolic syndrome and cancer risk. Specifically, we examine the hypothesis that individual components of the metabolic syndrome contribute to the development of several processes, including insulin resistance, aromatase activity, adipokine production, angiogenesis, glucose utilization, and oxidative stress/DNA damage, which can work together to increase cancer risk beyond that of the individual components alone. We propose that the metabolic syndrome be considered as a high-risk state for certain types of cancer and that this relationship should be systematically explored across cancer types.
Cowey
Stephanie
S
Department of Pathology, University of Alabama at Birmingham, 701 South 19th St., LHRB Room 531, Birmingham, AL 35294-0007, USA.
Hardy
Robert W
RW
D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications* / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology; D009369:Neoplasms / Q000150:complications* / Q000209:etiology* / Q000378:metabolism; D012307:Risk Factors